Haemophilus influenzae Type b Reemergence after Combination Immunization
An increase in Haemophilus influenzae type b (Hib) in British children has been linked to the widespread use of a diphtheria/tetanus/acellular pertussis combination vaccine (DTaP-Hib). We measured anti-polyribosyl-ribitol phosphate antibody concentration
Nik G. Johnson +9 more
doaj +3 more sources
Invasive Haemophilus influenzae Disease, Europe, 1996–2006 [PDF]
An international collaboration was established in 1996 to monitor the impact of routine Haemophilus influenzae type b (Hib) vaccination on invasive H. influenzae disease; 14 countries routinely serotype all clinical isolates.
Shamez Ladhani +5 more
doaj +2 more sources
Bacterial Meningitis and Haemophilus influenzae Type b Conjugate Vaccine, Malawi
A retrospective database review showed that Haemophilus influenzae type b conjugate vaccine decreased the annual number of cases of H. influenzae type b meningitis in children in Blantyre, Malawi. Among young bacterial meningitis patients, HIV prevalence
David W. McCormick +1 more
doaj +2 more sources
The authors studied the results of immunization among the children against the infection caused by haemophilus influenzae type B by two vaccines: ACT HIB and Hiberix.
V.V. Botvin’eva +3 more
doaj +3 more sources
Haemophilus influenzae Type b (Hib) Vaccines
Haemophilus influenzae is a human-restricted pathogen that colonises the nose and throat and to a lesser extent the conjunctivae and genital tract.
Slack, MPE
openaire +3 more sources
Shigeto Hamaguchi,1,* Masafumi Seki,1,* Norihisa Yamamoto,1 Tomoya Hirose,2 Naoya Matsumoto,2 Taro Irisawa,2 Ryosuke Takegawa,2 Takeshi Shimazu,2 Kazunori Tomono11Division of Infection Control and Prevention, 2Department of Traumatology and Acute ...
Hamaguchi S +8 more
doaj +1 more source
Economic evaluation of delivering Haemophilus influenzae type b vaccine in routine immunization services in Kenya. [PDF]
OBJECTIVE: Haemophilus influenzae type b (Hib) vaccine was introduced into routine immunization services in Kenya in 2001. We aimed to estimate the cost-effectiveness of Hib vaccine delivery. METHODS: A model was developed to follow the Kenyan 2004 birth
Akumu, Angela Oloo +8 more
core +1 more source
Cost-effectiveness of Haemophilus influenzae type b conjugate vaccine in low- and middle-income countries: regional analysis and assessment of major determinants. [PDF]
OBJECTIVES: To estimate the cost-effectiveness of Haemophilus influenzae type b (Hib) conjugate vaccine in low- and middle-income countries and identify the model variables, which are most important for the result.
Clark, Andrew +2 more
core +1 more source
Immunization coverage and risk factors for failure to immunize within the Expanded Programme on Immunization in Kenya after introduction of new Haemophilus influenzae type b and hepatitis b virus antigens [PDF]
Background: Kenya introduced a pentavalent vaccine including the DTP, Haemophilus influenzae type b and hepatitis b virus antigens in Nov 2001 and strengthened immunization services.
Cowgill, KD +40 more
core +1 more source
Comparative economic evaluation of Haemophilus influenzae type b vaccination in Belarus and Uzbekistan. [PDF]
BACKGROUND: Hib vaccine has gradually been introduced into more and more countries during the past two decades, partly due to GAVI Alliance support to low-income countries.
Tursunova Dilorom +27 more
core +1 more source

